BUY Asahi India Glass Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)4 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Asahi India Glass reported strong Q2 FY27 results with a 36.9% YoY revenue growth to ₹1,591 crore and a 76.4% YoY EBITDA growth to ₹351 crore.
NSE · Press Release·3 Nov · 3d ago
Asahi India Glass reported strong Q2 FY27 results with a 36.9% YoY revenue growth to ₹1,591 crore and a 76.4% YoY EBITDA growth to ₹351 crore, driven by robust automotive demand.
BSE · Company Update·3 Nov · 3d ago
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·9 Sept · 2mo ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Asahi India Glass
- BUY — Rakesh Bansal6 Nov 2026 · ~2 weeks · target ₹1,075 · Active
- BUY — Rakesh Bansal3 Nov 2026 · ~2 weeks · target ₹1,011 · Target hit
- BUY — Ashish Kyal, Waves Strategy Advisors3 Nov 2026 · ~2 weeks · target ₹1,000 · Target hit
- BUY — Vikas Sethi, Sethi Finmart30 Oct 2026 · ~2 weeks · target ₹950 · Target hit
- BUY — Osho Krishan, Angel One27 Oct 2026 · ~2 weeks · target ₹955 · Target hit
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

